12/2/24 19:50 | 12/2/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | D | | M.d | 74 | 29.55 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
12/2/24 19:50 | 12/2/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | D | | S.d | -123 | 49.00 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
9/17/24 18:20 | 9/17/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | D | | M.d | 322 | 23.86 | 0 | 14 | | 0 | D | | | | | | | | | | | | | | |
9/17/24 18:20 | 9/17/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | D | | S.d | -652 | 48.28 | 0 | -14 | -100 | 0 | D | | | | | | | | | | | | | | |
9/13/23 21:02 | 9/11/23 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | O | Chief Bu | M.dm | 19 | 3.30 | 0 | 6 | 2 | 263 | D | | | | | | | | | | | | | | |
9/13/23 21:02 | 9/11/23 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | O | Chief Bu | S.dm | -113 | 20.01 | 0 | -6 | -2 | 263 | D | | | | | | | | | | | | | | |
8/24/23 20:30 | 8/22/23 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | O | Chief Bu | M.d | 122 | 6.58 | 0 | 19 | 8 | 263 | D | | | | | | | | | | | | | | |
8/24/23 20:30 | 8/22/23 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | O | Chief Bu | S.d | -372 | 20.01 | 0 | -19 | -7 | 263 | D | | | | | | | | | | | | | | |
8/15/23 20:30 | 8/11/23 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | O | Chief Bu | M.d | 5 | 3.30 | 0 | 1 | 1 | 263 | D | | | | | | | | | | | | | | |
8/15/23 20:30 | 8/11/23 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | O | Chief Bu | S.d | -28 | 20.00 | 0 | -1 | -1 | 263 | D | | | | | | | | | | | | | | |
7/11/23 21:00 | 7/10/23 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | O | Chief Bu | M.d | 127 | 6.35 | 0 | 20 | 8 | 263 | D | | | | | | | | | | | | | | |
7/11/23 21:00 | 7/10/23 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | O | Chief Bu | S.d | -432 | 21.58 | 0 | -20 | -7 | 263 | D | | | | | | | | | | | | | | |
5/18/23 20:31 | 5/16/23 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | O | Chief Bu | S | -108 | 18.05 | 0 | -6 | -2 | 263 | D | | | | | | | | | | | | | | |
12/13/22 20:01 | 12/9/22 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | O | Chief Bu | M.d | 15 | 1.01 | 0 | 15 | 7 | 229 | D | | | | | | | | | | | | | | |
12/13/22 20:01 | 12/9/22 | REPL | Replimune Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Esposito Pamela | MA | O | Chief Bu | S.d | -375 | 25.03 | 0 | -15 | -6 | 229 | D | | | | | | | | | | | | | | |